LexDanaLexDanabeta
Inventor

XUEFEI TAN

Inventor
CN

Overview

2→
Patents
2024
Patent span
Human necessities
Primary field (CPC A)

Patents· 2 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations50%
C07DHeterocyclic compounds50%
PatentTitleYear
12,012,390Flavone compounds for the treatment and prophylaxis of hepatitis B virus disease202411,993,591Chromen-4-one derivatives for the treatment and prophylaxis of hepatitis B virus disease2024

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2024Patents assigned to HOFFMANN LA ROCHE (2)· patent assignee history
2024Based in CN· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
HOFFMANN LA ROCHE22024
Locations
LocationPatentsSpan
CN22024